Reduced neprilysin expression in Alzheimer's disease is associated with APOE E4 and cerebral amyloid angiopathy

Reduced neprilysin expression in Alzheimer's disease is associated with APOE E4 and cerebral amyloid angiopathy

Detalhes bibliográficos
Main Authors:	Miners, J, van Helmond, Z, Chalmers, K, Wilcock, G, Love, S, Kehoe, P
Formato:	Conference item
Publicado em:	2006

Registos relacionados

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
Por: Miners, J, et al.
Publicado em: (2006)

Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
Por: van Helmond, Z, et al.
Publicado em: (2007)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
Por: Chalmers, K, et al.
Publicado em: (2004)

APOE and cerebral amyloid angiopathy in the elderly.
Por: Love, S, et al.
Publicado em: (2003)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
Por: Williams, S, et al.
Publicado em: (2005)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease
Por: Williams, S, et al.
Publicado em: (2005)

Cerebral amyloid angiopathy in dementia and old age.
Por: Esiri, M, et al.
Publicado em: (1986)

Non-immunoglobin in cerebrospinal fluid of patients with Alzheimer's disease and cerebral amyloid angiopathy.
Por: Esiri, M, et al.
Publicado em: (1985)

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
Por: Chalmers, K, et al.
Publicado em: (2004)

Cerebral Amyloid Angiopathy
Por: Mahmut Edip Gürol
Publicado em: (2009-03-01)

Cerebral amyloid angiopathy
Por: Dan Popescu, et al.
Publicado em: (2010-06-01)

Cerebral amyloid angiopathy
Por: Tong HAN
Publicado em: (2014-01-01)

Iatrogenic cerebral amyloid angiopathy and Alzheimer's disease co‐pathology
Por: Francisco Hernández‐Fernández, et al.
Publicado em: (2025-01-01)

Image of Cerebral Amyloid Angiopathy in an Alzheimer's Disease Mouse Model
Por: Jinho Kim, et al.
Publicado em: (2015-01-01)

New therapeutic approaches for Alzheimer’s disease and cerebral amyloid angiopathy
Por: Satoshi eSaito, et al.
Publicado em: (2014-10-01)

Gait in Cerebral Amyloid Angiopathy
Por: Breni Sharma, et al.
Publicado em: (2022-10-01)

The role of neuroinflammation in cerebral amyloid angiopathy
Por: Hilde van den Brink, et al.
Publicado em: (2024-12-01)

Cerebral amyloid angiopathy related inflammation: An under recognized but treatable complication of cerebral amyloid angiopathy
Por: Alexander Berry-Noronha, MBBS, et al.
Publicado em: (2023-07-01)

Fluid biomarkers in cerebral amyloid angiopathy
Por: Seyed Mehrdad Savar, et al.
Publicado em: (2024-01-01)

Comorbidity of cerebral amyloid angiopathy and Alzheimer's disease. Clinical case analysis
Por: A. Yu. Emelin, et al.
Publicado em: (2023-12-01)

Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer’s disease and controls
Por: Chih-Hao Chen, et al.
Publicado em: (2023-04-01)

Progress in the study of the correlation between cerebral amyloid angiopathy and Alzheimer's disease
Por: LU Zheng⁃qi, et al.
Publicado em: (2021-10-01)

Cerebral achromatopsia secondary to cerebral amyloid angiopathy
Por: Michael D. Woods, et al.
Publicado em: (2025-03-01)

GAIT AND FALLS IN CEREBRAL AMYLOID ANGIOPATHY
Por: Breni Sharma, et al.
Publicado em: (2024-01-01)

CEREBROVASCULAR REACTIVITY IN CEREBRAL AMYLOID ANGIOPATHY
Por: Andrew E. Beaudin, et al.
Publicado em: (2024-01-01)

Cerebral Amyloid Angiopathy and Intracerebral Haemorrhage
Por: David Werring, et al.
Publicado em: (2016-09-01)

Superficial siderosis in cerebral amyloid angiopathy
Por: Wani Nisar, et al.
Publicado em: (2011-01-01)

Cerebral amyloid angiopathy (case report)
Por: L. A. Dobrynina, et al.
Publicado em: (2017-02-01)

Advances in cerebral amyloid angiopathy imaging
Por: Szu-Ju Chen, et al.
Publicado em: (2019-05-01)

Association of APOE genotype with CT markers of cerebral amyloid angiopathy in spontaneous intracerebral haemorrhage
Por: Feng Gao, et al.

Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons
Por: Hantian Hu, et al.
Publicado em: (2025-12-01)

Comparison of Plasma Lipoprotein Composition and Function in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Por: Anna Bonaterra-Pastra, et al.
Publicado em: (2021-01-01)

Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy
Por: Joseph O. Ojo, et al.
Publicado em: (2021-05-01)

Divergent brain solute clearance in rat models of cerebral amyloid angiopathy and Alzheimer’s disease
Por: Sunil Koundal, et al.
Publicado em: (2024-12-01)

The association between hypertensive angiopathy and cerebral amyloid angiopathy in primary intracerebral hemorrhage
Por: Yuyi Zhu, et al.
Publicado em: (2023-10-01)

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Por: Monica Xiong, et al.
Publicado em: (2023-03-01)

A case report of cerebral amyloid angiopathy
Por: Dong-Cen Hong, et al.
Publicado em: (2025-02-01)

Unilateral cerebral amyloid angiopathy after neurointervention
Por: A. Lázaro Romero, et al.
Publicado em: (2022-05-01)

Decreased Basal Ganglia Volume in Cerebral Amyloid Angiopathy
Por: Panagiotis Fotiadis, et al.
Publicado em: (2021-05-01)

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model
Por: Shin Heun Kim, et al.
Publicado em: (2020-11-01)